Gujarat Kidney And Super Speciality Limited

Gujarat Kidney And Super Speciality Limited (GKSL) is a micro-cap Healthcare company valued at ₹1,478 crore operating in Hospital on the NSE and BSE.

Recent price move

Gujarat Kidney And Super Speciality Limited last traded at ₹188.49, modestly down 0.61% on the day.

Recent developments

2026-06-30: The company reported its latest quarter results, showing revenue rose 124.7% compared to the same quarter a year earlier, but net profit remained flat at ₹5 crore. 2026-03-31: The company's revenue and net profit were ₹31 crore and ₹5 crore, respectively, showing a slight increase from the previous quarter.

Financial performance

The company's business is growing rapidly, with annual revenue rising 105.0% and net profit increasing 68.1% year-on-year. However, the net profit margin narrowed by 4.5 percentage points to 20.5%, while return on equity and return on capital employed remain low at 6.1% and 8.6%, respectively.

Valuation multiples

The stock trades at 95.7 times earnings, a premium to the Healthcare median of 32.0, 5.41 times book value.

Things to watch

The company's net profit margin has declined, which could signal pressure on profitability. Additionally, the stock is 7.4% below its 52-week high, and the company has not paid any dividends despite reporting profits.

Where it stands

The company has delivered strong revenue and profit growth over the past year and five years, but its net profit margin has declined, and it has not distributed any earnings to shareholders. The stock is currently trading 7.4% below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.